STOCK TITAN
  1. Home
  2. Sec-filings
  3. THC
  4. [Form 4] TENET HEALTHCARE CORP Insider Trading Activity

Tenet Healthcare (THC) EVP Paola Arbour converts 1,267 RSUs to stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Tenet Healthcare executive Paola M. Arbour, EVP and Chief Information Officer, reported the vesting and conversion of equity awards tied to her compensation. On February 24, 2026, 1,267 restricted stock units from her 2025 grant converted into an equal number of shares of Tenet common stock at no exercise price.

The restricted stock units were granted under the 2019 Stock Incentive Plan on February 24, 2025 and vest in three equal annual installments, with this filing covering the first one-third tranche. After these transactions, Arbour directly holds 2,534 restricted stock units and 40,271 shares of common stock, reflecting a routine employee equity vesting rather than an open-market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Arbour Paola M
Role EVP, Chief Information Officer
Type Security Shares Price Value
Exercise 2025 Restricted Stock Units 1,267 $0.00 $0.00
Exercise Common Stock 1,267 $0.00 $0.00
Holdings After Transaction: 2025 Restricted Stock Units — 2,534 shares (Direct); Common Stock — 40,271 shares (Direct)
Footnotes (3)
  1. F1. Restricted stock units convert into common stock on a one-for-one basis.
  2. F2. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2025, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on February 24, 2026.
  3. F3. Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What did Tenet Healthcare (THC) EVP Paola Arbour report in this Form 4?
Paola Arbour reported the vesting and conversion of 1,267 restricted stock units into 1,267 shares of Tenet Healthcare common stock. These equity awards are part of her compensation package under the 2019 Stock Incentive Plan and did not involve an open-market trade.

Were Tenet Healthcare (THC) shares bought or sold in Paola Arbour’s Form 4 filing?
No open-market buy or sell occurred; the Form 4 shows an exercise/conversion of derivative securities. 1,267 restricted stock units converted into the same number of common shares upon vesting under the company’s 2019 Stock Incentive Plan, at an exercise price of $0.0000 per share.

How many Tenet Healthcare (THC) shares does Paola Arbour hold after this Form 4?
After the reported transactions, Paola Arbour directly holds 40,271 shares of Tenet Healthcare common stock. She also directly holds 2,534 restricted stock units, which may convert into common shares in the future as they vest under the plan’s schedule.

What are the terms of Paola Arbour’s 2025 restricted stock units at Tenet Healthcare (THC)?
The 2025 restricted stock units were granted on February 24, 2025 under the 2019 Stock Incentive Plan. They vest in equal one-third installments on the first, second, and third anniversaries of the grant date, with the first one-third vesting on February 24, 2026.

How do Paola Arbour’s restricted stock units convert into Tenet Healthcare (THC) shares?
Her restricted stock units convert into common stock on a one-for-one basis when they vest. Upon each vesting event, time-based restricted stock units are settled in shares of Tenet Healthcare’s common stock, as reflected by the 1,267-unit conversion reported in this Form 4.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Arbour Paola M
(Last) (First) (Middle)
14201 DALLAS PARKWAY
(Street)
DALLAS TX 75254
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Chief Information Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/24/2026 M 1,267 A (1) 40,271 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
2025 Restricted Stock Units (2) 02/24/2026 M 1,267 (2) (2) Common Stock(3) 1,267 $0 2,534 D
Explanation of Responses:
1. Restricted stock units convert into common stock on a one-for-one basis.
2. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2025, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on February 24, 2026.
3. Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.
Chad J. Wiener, as Attorney-in-fact for Paola M. Arbour 02/26/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR